908 organization(s) found
RCI (Rwanda Cancer Institute)
Provides cancer treatment, research, and training across Rwanda.
Regeneron
We are a leading biotechnology company that invents, develops and commercializes life-transforming medicines for people with serious diseases. Founded and led by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to numerous approved treatments and product candidates in development, almost all of which were homegrown in our laboratories. Regeneron's medicines and pipeline are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, neurological diseases, hematologic conditions, infectious diseases and rare diseases.
RemeGen
RemeGen is committed to the discovery, development, production and commercialization of first-in-class and best-in-class biological drugs, and has developed a series of innovative biologics with significant clinical value for major diseases such as autoimmunity, oncology, and ophthalmology.
Resilience Care
At Resilience Care, we believe that digital innovation can transform the way we deliver care � making it more patient-centered, personalized and equitable. Our story, vision, and team reflect a shared commitment: to deliver better care by placing patients at the heart of care and clinical research.
Revolution Medicines
We are Revolutionaries – passionate in our singular pursuit of discovering, developing and delivering innovative, targeted medicines for patients living with cancer. To deliver on our vision, we work relentlessly in pursuit of cutting-edge therapeutic approaches to some of the toughest cancers. Our current focus is on RAS-addicted cancers, which account for 30 percent of all new human cancer diagnoses. With our deep pipeline of RAS(ON) inhibitors, we are pioneering a new way of drugging the previously undruggable, with the potential to change the treatment paradigm for many patients living with RAS-addicted cancer.
Rigel Pharmaceuticals
Biotechnology company focused on hematologic disorders and cancer, with a product for IDH1-mutated acute myeloid leukemia.
Roche
We focus on discovering new medicines, diagnostics and digital products that improve health outcomes, so that we all have more time with the people we love.
Roche Diagnostics (a member of the Roche group)
Roche Diagnostics empowers researchers and clinicians by providing one of the industry's most comprehensive testing portfolio of innovative diagnostic solutions, encompassing clinical chemistry and immunoassays to point of care testing and laboratory automation.
Royal Melbourne Hospital - Parkville / Victorian Comprehensive Cancer Centre and Parkville Familial Cancer Centre
Ruijin Hospital
Chinese university hospital that hosts the Shanghai Institute of Hematology, known for its work on acute promyelocytic leukemia.
Ryvu Therapeutics
Biotechnology company that develops small molecules for blood cancers.
SalubrisBio
SalubrisBio is a clinical-stage biotechnology company dedicated to discovering and developing novel antibody and protein-based therapeutics. We are developing innovative and transformative therapeutic molecules to provide clinically meaningful improvements in disease burden and quality of life for patients with significant unmet medical needs.
Sana Biotechnology
Sana was founded with the long view � bringing together great people and the best technologies to deliver on the challenging promise of engineered cells as medicines.
SBCO (Brazilian Society of Surgical Oncology)
The Brazilian Society of Surgical Oncology– SBCO is a non-profit organization founded on May 31st, 1988, with the goal of bringing together surgical oncologists and other professionals involved in the care of people with cancer. SBCO is the “home” of physicians and healthcare professionals involved in the overall management of surgical patients with cancer in Brazil. Join SBCO and share knowledge.
SCON (Société camerounaise d’oncologie)
In French: "La Société Camerounaise d'Oncologie a pour objet de fédérer les Cancérologues Camerounais"